'Log rank' presentation slideshows

Upcoming Events

Upcoming Events. Thursday, April 25: Group 8 presentation on interim analysis Tuesday, April 30: Groups 1 and 2 HIV early treatment presentations; assignment 3 due Thursday, May 2: Groups 3 and 4 HF presentations Tuesday, May 7: Groups 5 and 6 polypill x aspirin presentations

800 views • 66 slides

Communication Complexity: An introduction, survey, and open problems

832 views • 62 slides

Metastatic Renal Cell Carcinoma

The Ever-Changing Landscape Daniel Heng MD MPH FRCPC University of Calgary. Metastatic Renal Cell Carcinoma. Outline. Staging Genetics behind RCC Treatment of metastatic disease Case Prognostic Factors Mechanisms of Resistance Cytoreductive nephrectomy. Staging. Cohen et al NEJM 2004.

959 views • 52 slides

Taxotere in the Management of Early-Stage Breast Cancer: Improving Outcomes

795 views • 47 slides

Taxotere in the Management of Early-Stage Breast Cancer: Improving Outcomes

601 views • 47 slides

Logistic Regression & Survival Analysis

Logistic Regression & Survival Analysis. Analysis of binary outcome & time to event data Larry Holmes, Jr Joabyer Hossain. Stats Research, Lecture 7. November 13, 2008. Presentation Objectives. At the end of this presentation, participants should be able to :

1.05k views • 42 slides

A Survivor's Guide to Survival Analysis

532 views • 34 slides

507 views • 32 slides

HSRP 734: Advanced Statistical Methods July 10, 2008

HSRP 734: Advanced Statistical Methods July 10, 2008. Objectives. Describe the Kaplan-Meier estimated survival curve Describe the log-rank test Use SAS to implement. Kaplan-Meier Estimate of Survival Function S(t).

493 views • 27 slides

G. Fiorentini 1 , C. Aliberti 2 , G. Benea 2 , G. Turrisi 1 , A. Mambrini 3 , I. Marri 2 , M. Tilli 2 .

RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL ASSESSING SURVIVAL AT 3 YEARS OF POLYVINYL ALCOHOL MICROSPHERES PRELOADED WITH IRINOTECAN (DEBIRI) VS. FOLFIRI IN PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL CANCER.

464 views • 26 slides

The Influence of Proton Pump Inhibitors on Clinical Outcomes After Successful Percutaneous Coronary Intervention

The Influence of Proton Pump Inhibitors on Clinical Outcomes After Successful Percutaneous Coronary Intervention . Kishore J. Harjai, MD, FACC Chetan Shenoy, MD Pamela Orshaw, RN Judith Boura, MS Guthrie Health Care System, Sayre, PA. Background.

548 views • 24 slides

Exploratory Data Analysis Approaches to Reliability: Some New Directions

Exploratory Data Analysis Approaches to Reliability: Some New Directions. Chris McCollin Cornel Bunea Maria Ramalhoto. Chris McCollin The Nottingham Trent University. Involved in Reliability since 1976 Worked as a reliability engineer for 3 major aerospace companies

478 views • 23 slides

Statistical Review: Recursive Partitioning Identifies Patients at High and Low Risk for Ipsilateral Tumor Recurrence After Breast-Conserving Surgery and Radiation Freedman, Hanlon, Fowble, Anderson, and Nicolaou JCO, October 2002. Analytic Method: Recursive Partitioning Analysis

343 views • 20 slides

H. Narahara 1 , W. Koizumi 2 , T. Hara 3 , A. Takagane 4 , T. Akiya 5 ,

Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment of advanced gastric cancer ( The SPIRITS trial ) SPIRITS: S -1 plus cis p latin vs S-1 i n R CT i n the t reatment of s tomach cancer. H. Narahara 1 , W. Koizumi 2 , T. Hara 3 , A. Takagane 4 , T. Akiya 5 ,

369 views • 20 slides

Disclosures

Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis: AQUARIUS Study Results. SJ Nicholls, GL Bakris , JJP Kastelein , V Menon , B Williams, M Nicolaides , P Brunel, J Armbrecht , R Puri , D Bash, A Hsu and SE Nissen. Disclosures.

378 views • 20 slides

Presented by: Melanie Camacho

The Effects of p53 Status and Human Papillomavirus Infection on the Clinical Outcome of Patients with Stage IIIB Cervical Carcinoma Treated with Radiation Therapy Alone. Presented by: Melanie Camacho

211 views • 19 slides

C. Michael Gibson, MS, MD on behalf of the ATLAS ACS 2 TIMI 51 Investigators

A nti- Xa T herapy to L ower Cardiovascular Events in A ddition to Standard Therapy in S ubjects with A cute C oronary S yndrome - Thrombolysis in Myocardial Infarction 51 Trial (ATLAS ACS 2 - TIMI 51):

383 views • 18 slides

BR.21 Study Design

255 views • 14 slides

Introduction

114 views • 1 slides

ABSTRACT

KRAS MUTATION, CANCER RECURRENCE AND PATIENT SURVIVAL IN STAGE III COLON CANCER: FINDINGS FROM CALGB 89803

91 views • 1 slides